Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.
about
Biological markers of invasive breast cancerCirculating DNA as biomarker in breast cancerFree DNA--new potential analyte in clinical laboratory diagnostics?The Roles of Mitochondrial Damage-Associated Molecular Patterns in DiseasesOrigins, structures, and functions of circulating DNA in oncologyMethyl-binding domain protein-based DNA isolation from human blood serum combines DNA analyses and serum-autoantibody testing.Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers.Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysisRepeated bouts of exhaustive exercise increase circulating cell free nuclear and mitochondrial DNA without development of tolerance in healthy menCirculating Tumor Nucleic Acids: Perspective in Breast Cancer.Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammationThe plasma mitochondrial DNA is an independent predictor for post-traumatic systemic inflammatory response syndrome.An exposure to the oxidized DNA enhances both instability of genome and survival in cancer cells.Mitochondrial dysfunction in cancer cells due to aberrant mitochondrial replication.Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer.Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients.Silencing of uncoupling protein 2 by small interfering RNA aggravates mitochondrial dysfunction in cardiomyocytes under septic conditions.Very Short Mitochondrial DNA Fragments and Heteroplasmy in Human Plasma.Quantitative analysis of cell-free DNA in ovarian cancer.Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.Plasma cell-free mitochondrial DNA declines in response to prolonged moderate aerobic exercise.Prevalent coordination of mitochondrial DNA transcription and initiation of replication with the cell cycleCell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's DiseasePotential biomarkers to follow the progression and treatment response of Huntington's disease.Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients.Circulating nucleic acids as biomarkers in breast cancer.Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content.Circulating cell-free mitochondrial DNA as a novel cancer biomarker: opportunities and challenges.Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.A headlight on liquid biopsies: a challenging tool for breast cancer management.The pharmacoepigenetics of drug metabolism and transport in breast cancer: review of the literature and in silico analysis.Beneficial effects of exercise on age-related mitochondrial dysfunction and oxidative stress in skeletal muscle.Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases.Fueling Inflamm-Aging through Mitochondrial Dysfunction: Mechanisms and Molecular Targets.Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson's disease.
P2860
Q26781177-2E381D48-DF70-48A9-991A-1C93724614F7Q26785343-BE7F2ECF-6EE8-4D0F-9DE8-4E870C50C458Q26863327-3408B57F-A8EE-4C2C-943B-C1B477F1CFA4Q28396823-C2A9EB2A-E474-4AEF-9BDB-54F51D3DB455Q30249103-30C44622-7102-4C7E-AD63-78BDA748AB7AQ31030113-9AECEE8E-4715-4AF5-B49B-8319D0E6896AQ33577711-47ACAE85-E7A0-4F7B-B974-19F99D4F0797Q33600363-90F2488F-E926-4117-88B2-048FE4B5E664Q33629819-53FCA39C-23B7-47E7-BCB4-C38453BCD1F9Q33688767-9E7F3FE4-4E3B-43E5-9C63-21392FB94645Q33725026-4D7500F1-05F8-40F0-8F96-549E2CCD56C9Q34096001-9AA3FF12-1E93-4AEF-8133-38422EEAE7CDQ34660102-CA9DCB7B-CA54-4668-9BB6-AFFFCD8E5A2BQ34974108-F539DBDC-5EB4-410A-964E-8081BC5CB496Q35023150-9CCBC8AB-C5C6-4619-8BEE-24D59D24B367Q35063098-CC2607B7-8125-4BB9-8895-904FB1798BF2Q35148262-BD0F746F-E6E5-4C7B-96D2-06C4BB4E5A1BQ35558298-9A71D925-901C-4E66-B4EB-9BE40A5EB83CQ35609951-957FF1AC-DC68-46E2-9F46-0B0E9E1F6EE3Q36181880-357CCCB9-1ED0-408A-AD1C-552C8AA14362Q36334715-2C52D240-6AA0-4B82-AD0A-ABE20D7C2638Q36557431-85A0553D-985B-4EF8-837D-F21FD63A57CFQ36597722-E5855D8D-2649-439B-9195-F5F9FA9C770EQ36684815-28507E5F-16AF-4EC8-891A-FB9DA3530CC2Q36785190-CAC08F8D-60AB-499E-89CC-0BF169CCDA37Q37014663-229DE5C6-879E-4F2B-AC72-D6B48CD9FF7BQ37256739-35506196-491B-46FE-8260-CE6EC37D2A51Q37415254-069F1D01-0129-4243-85DE-EC725ADFC6BDQ37522662-735F5D7E-62C0-43A8-B6AD-CEF883D4C55DQ37690204-840F8A13-9B5D-4A46-B8B3-1CB9B97939BAQ38002456-2C59C518-4B9E-4390-9C5E-E8B2CAA41171Q38024847-127000C2-0E6C-47CC-95EB-CBDD84C24E26Q38047337-BAF76C4A-EC7A-4BF3-975C-736F192D24F8Q38669236-684F6E17-3A5C-4C61-BB2F-CEBA6673D744Q38704258-0271E9B9-C1C9-4030-BDF3-957896F465A4Q38937221-8948E6E4-0DA1-4069-A17C-83700FDB09C9Q38949760-3B7EE0F2-D50B-4CBE-A56E-8FE8F8583325Q39181159-E1034CB2-B093-4584-B99B-A34E80CCDD80Q39269625-A555687B-E453-48F0-ABC2-923B96B4C4B1Q40568866-784A208C-F829-43F5-9201-A316B014ABC3
P2860
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Levels of plasma circulating c ...... biomarkers for breast tumors.
@en
Levels of plasma circulating c ...... biomarkers for breast tumors.
@nl
type
label
Levels of plasma circulating c ...... biomarkers for breast tumors.
@en
Levels of plasma circulating c ...... biomarkers for breast tumors.
@nl
prefLabel
Levels of plasma circulating c ...... biomarkers for breast tumors.
@en
Levels of plasma circulating c ...... biomarkers for breast tumors.
@nl
P2093
P2860
P356
P1433
P1476
Levels of plasma circulating c ...... l biomarkers for breast tumors
@en
P2093
Claude Diesch
Corina Kohler
Edward Wight
Johannes Bitzer
Nicole Bürki
Reza Asadollahi
Wolfgang Holzgreve
Xiao Yan Zhong
Zeinab Barekati
P2860
P2888
P356
10.1186/1476-4598-8-105
P577
2009-11-17T00:00:00Z
P5875
P6179
1025246487